Algo version: 0.98b
Hypera S.A. is listed at the OTC Exchange
Hypera S.A. [HYPMY]
OTC Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is Hypera S.A. stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Hypera S.A. pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Thursday 1st of August 2024 were paid $0.00314496 per share. Over the last 39 times between 2011 and 2024, Hypera S.A. has paid $0.72449267 with an average of $0.02 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Hypera S.A. 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was $7.79, you would have made a loss of $-2.89 per share or -37.10%

No, the average daily trading liquidity for Hypera S.A. is $13 954 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Hypera S.A. has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.18, the company's ability to pay off the debt is normal. Hypera S.A. has a very good net profit margin of 21.16% and should have very high tolerances against inflation.

We have calculated the inflation risk for Hypera S.A. to be low [0.3 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.